168 related articles for article (PubMed ID: 29656002)
1. Dangers of outpatient nimodipine use after spontaneous subarachnoid hemorrhage in accordance with the Comprehensive Stroke Center guidelines.
Chen CJ; Turnage C; Sokolowski JD; Kumar JS; Kalani MY; Park MS
J Clin Neurosci; 2018 Jun; 52():151-152. PubMed ID: 29656002
[TBL] [Abstract][Full Text] [Related]
2. Poor Utilization of Nimodipine in Aneurysmal Subarachnoid Hemorrhage.
Hajizadeh Barfejani A; Rabinstein AA; Wijdicks EFM; Clark SL
J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2155-2158. PubMed ID: 31103551
[TBL] [Abstract][Full Text] [Related]
3. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
[TBL] [Abstract][Full Text] [Related]
4. Effects of 14 Versus 21 Days of Nimodipine Therapy on Neurological Outcomes in Aneurysmal Subarachnoid Hemorrhage Patients.
Cho S; Bales J; Tran TK; Korab G; Khandelwal N; Joffe AM
Ann Pharmacother; 2016 Sep; 50(9):718-24. PubMed ID: 27273676
[TBL] [Abstract][Full Text] [Related]
5. Intra-arterial nimodipine infusion for cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage.
Cho WS; Kang HS; Kim JE; Kwon OK; Oh CW; Son YJ; Know BJ; Jung C; Hang MH
Interv Neuroradiol; 2011 Jun; 17(2):169-78. PubMed ID: 21696654
[TBL] [Abstract][Full Text] [Related]
6. Hypotensive effect of nimodipine during treatment for aneurysmal subarachnoid haemorrhage.
Porchet F; Chioléro R; de Tribolet N
Acta Neurochir (Wien); 1995; 137(1-2):62-9. PubMed ID: 8748871
[TBL] [Abstract][Full Text] [Related]
7. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
van den Bergh WM; Mees SM; Rinkel GJ
Neurosurgery; 2006 Nov; 59(5):E1152; author reply E1152. PubMed ID: 17143226
[No Abstract] [Full Text] [Related]
8. Nimodipine Dose Reductions in the Treatment of Patients with Aneurysmal Subarachnoid Hemorrhage.
Sandow N; Diesing D; Sarrafzadeh A; Vajkoczy P; Wolf S
Neurocrit Care; 2016 Aug; 25(1):29-39. PubMed ID: 26690937
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of fasudil in patients with subarachnoid hemorrhage: final results of a randomized trial of fasudil versus nimodipine.
Zhao J; Zhou D; Guo J; Ren Z; Zhou L; Wang S; Zhang Y; Xu B; Zhao K; Wang R; Mao Y; Xu B; Zhang X;
Neurol Med Chir (Tokyo); 2011; 51(10):679-83. PubMed ID: 22027241
[TBL] [Abstract][Full Text] [Related]
10. Single-Dose Intraventricular Nimodipine Microparticles Versus Oral Nimodipine for Aneurysmal Subarachnoid Hemorrhage.
Carlson AP; Hänggi D; Wong GK; Etminan N; Mayer SA; Aldrich F; Diringer MN; Schmutzhard E; Faleck HJ; Ng D; Saville BR; Bleck T; Grubb R; Miller M; Suarez JI; Proskin HM; Macdonald RL;
Stroke; 2020 Apr; 51(4):1142-1149. PubMed ID: 32138631
[TBL] [Abstract][Full Text] [Related]
11. Clinical Trial Protocol: Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study Comparing EG-1962 to Standard of Care Oral Nimodipine in Adults with Aneurysmal Subarachnoid Hemorrhage [NEWTON-2 (Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After SubarachNoid Hemorrhage)].
Hänggi D; Etminan N; Mayer SA; Aldrich EF; Diringer MN; Schmutzhard E; Faleck HJ; Ng D; Saville BR; Macdonald RL;
Neurocrit Care; 2019 Feb; 30(1):88-97. PubMed ID: 30014184
[TBL] [Abstract][Full Text] [Related]
12. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
[TBL] [Abstract][Full Text] [Related]
13. Randomized, Open-Label, Phase 1/2a Study to Determine the Maximum Tolerated Dose of Intraventricular Sustained Release Nimodipine for Subarachnoid Hemorrhage (NEWTON [Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage]).
Hänggi D; Etminan N; Aldrich F; Steiger HJ; Mayer SA; Diringer MN; Hoh BL; Mocco J; Faleck HJ; Macdonald RL;
Stroke; 2017 Jan; 48(1):145-151. PubMed ID: 27932607
[TBL] [Abstract][Full Text] [Related]
14. Nimodipine treatment of subarachnoid hemorrhage.
Laursen J; Jensen F; Mikkelsen E; Jakobsen P
Clin Neurol Neurosurg; 1988; 90(4):329-37. PubMed ID: 3233859
[TBL] [Abstract][Full Text] [Related]
15. Continuous intra-arterial nimodipine infusion in patients with severe refractory cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a feasibility study and outcome results.
Bele S; Proescholdt MA; Hochreiter A; Schuierer G; Scheitzach J; Wendl C; Kieninger M; Schneiker A; Bründl E; Schödel P; Schebesch KM; Brawanski A
Acta Neurochir (Wien); 2015 Dec; 157(12):2041-50. PubMed ID: 26439105
[TBL] [Abstract][Full Text] [Related]
16. Nimodipine: test your drug IQ.
Devlin MM
Nursing; 2008 Jul; 38(7):56cc1-2. PubMed ID: 18580671
[TBL] [Abstract][Full Text] [Related]
17. Nimodipine-associated standard dose reductions and neurologic outcomes after aneurysmal subarachnoid hemorrhage: the era of pharmacogenomics.
Vázquez-Medina A; Turnbull MT; James CL; Cowart JB; Lesser E; Carter RE; Ross OA; Miller DA; Meschia JF; De Jesús Espinosa A; Weinshilboum R; Freeman WD
Pharmacogenomics J; 2024 Jun; 24(4):19. PubMed ID: 38890281
[TBL] [Abstract][Full Text] [Related]
18. Nimodipine after aneurysmal subarachnoid hemorrhage: Fourteen-day course for patients that meet criteria for early hospital discharge.
Sokolowski JD; Chen CJ; Soldozy S; Mastorakos P; Burke RM; Nguyen JM; Myers KM; Kalani MYS; Park MS
Clin Neurol Neurosurg; 2021 Jan; 200():106299. PubMed ID: 33092929
[TBL] [Abstract][Full Text] [Related]
19. Nimodipine in subarachnoid hemorrhage.
DiPalma JR
Am Fam Physician; 1989 Dec; 40(6):143-5. PubMed ID: 2686374
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenomics of Cytochrome P450 of Nimodipine Metabolism After Aneurysmal Subarachnoid Hemorrhage.
Peacock SH; James C; Turnbull MT; Cowart JB; Reid JM; Freeman WD
J Neurosci Nurs; 2019 Oct; 51(5):238-242. PubMed ID: 31469704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
